TGFB1 and systemic sclerosis: TGF-β–treated SSc fibroblasts demonstrated a significant reduction in TGF-β–induced α-SMA expression (P = 0.03) and showed a trend toward reduced Col1a1 expression, whereas no reduction in fibrotic gene expression was observed in healthy control fibroblasts (Supplemental Figure 4).